Vantage Consulting Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,798
Closed -$223K 113
2024
Q2
$223K Sell
1,798
-127
-7% -$16.4K 0.17% 160
2024
Q1
$254K Sell
1,925
-329
-15% -$40.6K 0.16% 107
2023
Q4
$246K Buy
2,254
+126
+6% +$13.1K 0.17% 126
2023
Q3
$219K Buy
2,128
+53
+3% +$5.71K 0.15% 160
2023
Q2
$239K Sell
2,075
-147
-7% -$16.7K 0.14% 148
2023
Q1
$236K Sell
2,222
-3
-0.1% -$324 0.13% 180
2022
Q4
$247K Sell
2,225
-718
-24% -$73.4K 0.15% 134
2022
Q3
$253K Buy
2,943
+180
+7% +$16.1K 0.15% 105
2022
Q2
$252K Sell
2,763
-172
-6% -$15.2K 0.14% 120
2022
Q1
$241K Sell
2,935
-644
-18% -$50.8K 0.09% 159
2021
Q4
$274K Buy
3,579
+260
+8% +$20.7K 0.07% 149
2021
Q3
$249K Buy
3,319
+333
+11% +$25.3K 0.05% 129
2021
Q2
$232K Buy
+2,986
New +$222K 0.04% 159
2021
Q1
Sell
-919
Closed -$72K 997
2020
Q4
$72K Buy
+919
New +$70.3K 0.01% 306

Other funds holding MRK

Vantage Consulting Group's MRK Position: Q3 2024 in Review

Vantage Consulting Group sold out of Merck (MRK) in Q3 2024, closing a stake of 1,798 shares — an estimated $223K sold.

Vantage Consulting Group first reported a position in MRK in Q4 2020 and held it in 14 quarters. The position peaked at $274K in Q4 2021. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Vantage Consulting Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 1,798 Merck shares in Q3 2024, an estimated $223K.
  • Vantage Consulting Group first reported a position in Merck in Q4 2020 and held it in 14 quarters.
  • Vantage Consulting Group's Merck position peaked at $274K in Q4 2021.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.